Medicine & AI to Improve Outcomes by Discovering Undiagnosed Patients- NHS Clinicians Presenting at HIMSS

Predicting Length-of-Stay & Risk of Mortality for ICU Patients

Pangaea Data Awarded Top Tier Co-Sell Partnership Status by Microsoft

Pangaea Named ‘Digital Solution of the Year’ by UK Government’s Department for International Trade

WHITEPAPER: How can Pharmaceutical & Healthcare Providers Collaborate in a Financially Sustainable & Scalable Manner to Improve Patient Outcomes?

Go back

Medicine & AI to Improve Outcomes by Finding 6x More Untreated Patients

10:15- 11:15AM BST, Microsoft Booth (D10), June 12th & June13th 2024, Manchester, UK

Location: Microsoft Booth (D10)

Venue: Manchester Central, Manchester, UK

Up to 90% patients across 7,000 conditions are untreated (undiagnosed, misdiagnosed, miscoded, uncontrolled, at-risk). For example, cachexia (muscle wasting disease) is estimated to impact over 90% of cancer patients and result in 20% of casualties, however, over 50% of these patients are currently untreated. Through the application of Pangaea’s platform which imbibes AI based on clinical guidelines, NHS oncosurgeons found 6 times more untreated cachectic cancer patients compared to metadata and pre-emptive NLP approaches. The discovery of these untreated patients is leading to improved outcomes, halving treatment costs, improving resource optimisation and ensuring that patients are on guideline concordant therapies or trials.

Please let us know if you are available to meet by registering through the form below or emailing us at info@pangaeadata.ai

Register to Meet Us

Presenter

Dr. Vibhor Gupta
Director & Founder
Pangaea Data